Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
RANI

Updated 10/6/2026, 8:56 AM ET.

RANI

Rani Therapeutics Holdings, Inc.

Buy$24,840

IMRAN MIR A

Director, 10% owner

36,000 shat $0.69Filed Jul 23, 4:10 PM ETFiling
RANI

Rani Therapeutics Holdings, Inc.

Sale$301

Javadi Alireza

Chief Technical Officer

386 shat $0.78Filed Jul 21, 7:24 PM ETFiling
RANI

Rani Therapeutics Holdings, Inc.

Buy$25,193

Imran Talat

Chief Executive Officer, Director

35,000 shat $0.72Filed Jul 21, 6:29 PM ETFiling
RANI

Rani Therapeutics Holdings, Inc.

Sale$11,300

Imran Talat

Chief Executive Officer, Director

8,014 shat $1.41Filed Jul 21, 6:25 PM ETFiling

Read from public SEC filings. Not financial advice.